QIAGEN N.V. QGEN

Latest FY: 2025 Healthcare Diagnostics & Research
Market Price $42.98
Market Cap $8.92B
P/E Ratio 22.15
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑5.7% YoY
$2.09B
3-Yr CAGR: -0.8%
Net Income ↑408.3% YoY
$424.88M
Net Margin: 20.3%
Free Cash Flow ↓-10.5% YoY
$453.28M
FCF Yield: 5.08%
EPS (Diluted) ↑424.3% YoY
$1.94
Basic: $1.96
Return on Equity Efficiency
11.2%
ROA: 221.7%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (QGEN)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $1,338.0M $844.7M $80.4M $0.34 $341.6M $267.1M
FY 2017 $1,417.5M +5.9% $922.6M $40.4M -49.8% $0.17 -50.0% $286.8M $196.7M -26.3%
FY 2018 $1,501.8M +5.9% $1,001.0M $190.4M +371.3% $0.82 +382.4% $359.5M $249.7M +27.0%
FY 2019 $1,526.4M +1.6% $1,005.3M $-41.5M -121.8% $-0.18 -122.0% $330.8M $212.9M -14.7%
FY 2020 $1,870.3M +22.5% $1,232.7M $359.2M +966.5% $1.53 +950.0% $457.8M $325.0M +52.7%
FY 2021 $2,251.7M +20.4% $1,450.8M $512.6M +42.7% $2.21 +44.4% $639.0M $449.1M +38.2%
FY 2022 $2,141.5M -4.9% $1,384.6M $423.2M -17.4% $1.84 -16.7% $715.3M $586.0M +30.5%
FY 2023 $1,965.3M -8.2% $1,233.7M $341.3M -19.4% $1.48 -19.6% $459.5M $309.7M -47.1%
FY 2024 $1,978.2M +0.7% $967.4M $83.6M -75.5% $0.37 -75.0% $673.6M $506.4M +63.5%
FY 2025 $2,090.0M +5.7% $1,299.5M $424.9M +408.3% $1.94 +424.3% $654.3M $453.3M -10.5%
$

Valuation

Market Price $42.98
Market Cap $8.92B
Enterprise Value $9.73B
P/E Ratio 22.15
P/B Ratio 2.35
FCF Yield 5.08%
Dividend Yield 0.58%
Shares Outstanding 206,250,000
%

Profitability & Margins

Gross Margin 62.18%
Operating Margin 22.29%
Net Margin 20.33%
Return on Equity (ROE) 11.25%
Return on Assets (ROA) 221.69%
Asset Turnover 10.90x
Revenue 3-Yr CAGR -0.81%
🛡️

Financial Health & Liquidity

Current Ratio 3.34
Cash Ratio 14.63
Debt / Equity 0.438
Debt / Assets 8.632
Cash & Equivalents $839.00M
Total Debt $1.65B
Book Value / Share $18.32
💧

Cash Flow Efficiency

Operating Cash Flow $654.33M
Capital Expenditures (CapEx) $201.05M
Free Cash Flow $453.28M
OCF / Revenue 31.31%
FCF / Revenue 21.69%
FCF 3-Yr CAGR -8.21%
🏷️

Per Share Metrics

EPS (Diluted) $1.94
EPS (Basic) $1.96
Dividends / Share $0.25
Book Value / Share $18.32
EPS YoY Growth 424.32%
🏛️

Balance Sheet (FY 2025)

Total Assets $191.66M
Total Liabilities $57.34M
Stockholders' Equity $3.78B
Current Assets $191.66M
Current Liabilities $57.34M